Senior insider sale
General Counsel at ARROWHEAD PHARMACEUTICALS, INC. — senior position signals high conviction
$3.12M
49.49K shares
What this filing means
O'BRIEN PATRICK plans to sell 49.49K shares of ARROWHEAD PHARMACEUTICALS, INC. valued at approximately $3.12M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/5/2026ACC: 0001628280-26-000575
Officer· General Counsel
Since Jan 2019
49.49K
Shares to sell
$3.12M
Approx. market value
344.31K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months6
Compensation
Compensation
1/4/2025
100KCompensation
Compensation
1/4/2024
85KCompensation
Compensation
1/4/2023
65KCompensation
Compensation
1/4/2023
17.50KCompensation
Compensation
1/2/2023
16.81KCompensation
Compensation
1/1/2022
60KTotal acquired344.31K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/4/2025 | Compensation Compensation | 100K | — |
1/4/2024 | Compensation Compensation | 85K | — |
1/4/2023 | Compensation Compensation | 65K | — |
1/4/2023 | Compensation Compensation | 17.50K | — |
1/2/2023 | Compensation Compensation | 16.81K | — |
1/1/2022 | Compensation Compensation | 60K | — |
| Total | 344.31K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
49.49K
Market value
$3.12M
1/5/2026
Total
Units
49.49K
Value
$3.12M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/5/2026 | 49.49K | $3.12M | NASDAQ | Planned |
| Total | 49.49K | $3.12M | ||